C7A.1
Billable
Malignant poorly differentiated neuroendocrine tumors
C7A.1 is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Malignant poorly differentiated neuroendocrine tumors
C7A.1 is billable and can be used for reimbursement purposes.